Abstract C170: GDC-0941 inhibits cytarabine-induced PI3K/AKT signaling and promotes synergistic activity in acute myeloid leukemia.
Christina D. Drenberg(The Ohio State University), Sharyn D. Baker(The Ohio State University), Brian Fermanski(St. Jude Children's Research Hospital), Yiping Fan(St. Jude Children's Research Hospital), Laura J. Janke(St. Jude Children's Research Hospital), Steven Zatechka(St. Jude Children's Research Hospital), Shelley Orwick(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
The genomic landscape of hypodiploid acute lymphoblastic leukemia
|Nature Genetics|2013|737
CREBBP mutations in relapsed acute lymphoblastic leukaemia
|Nature|2011|638
The genomic landscape of pediatric acute lymphoblastic leukemia
|Nature Genetics|2022|412